A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction in Pediatric Patients Aged 4 to 14 Years.

Trial Profile

A Double-Blind, Placebo-Controlled, Multicenter, Crossover Study to Evaluate the Effects of a Single Oral Dose of Montelukast, Compared With Placebo, on Exercise-Induced Bronchoconstriction in Pediatric Patients Aged 4 to 14 Years.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs Montelukast (Primary)
  • Indications Exercise-induced asthma
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 01 Nov 2011 Results published in Allergy and Asthma Proceedings.
    • 06 Apr 2011 Actual patient number added, as reported by ClinicalTrials.gov.
    • 30 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top